Overview
Primary interstitial lung disease specific to childhood due to alveolar structure disorder (also referred to as childhood ILD related to alveolar structure disorder or chILD due to alveolar structure disorder) is a group of rare lung diseases that affect infants and young children. These conditions are characterized by abnormal development or disruption of the alveolar structures — the tiny air sacs in the lungs where gas exchange occurs. The alveoli may be simplified, enlarged, or structurally disorganized, leading to impaired oxygen exchange and respiratory insufficiency. This category encompasses conditions such as alveolar simplification (including that seen in prematurity-related lung disease), alveolar growth abnormalities, and certain forms of pulmonary hypoplasia that present in childhood. Clinically, affected children typically present with persistent tachypnea (rapid breathing), hypoxemia (low blood oxygen levels), respiratory distress, failure to thrive, and exercise intolerance. Symptoms often manifest in the neonatal or infantile period and can range from mild chronic respiratory symptoms to severe, life-threatening respiratory failure. Chest imaging commonly reveals diffuse interstitial changes, and lung biopsy — when performed — shows characteristic alveolar architectural abnormalities such as deficient alveolarization or lobular simplification. There is no specific curative treatment for these disorders. Management is primarily supportive and may include supplemental oxygen therapy, nutritional support, mechanical ventilation in severe cases, and anti-inflammatory medications such as systemic corticosteroids or hydroxychloroquine, though evidence for pharmacological therapies remains limited. In the most severe and progressive cases, lung transplantation may be considered. The prognosis is highly variable depending on the specific underlying alveolar structural abnormality and its severity. Some children may show gradual improvement with lung growth, while others experience chronic respiratory impairment. Long-term multidisciplinary follow-up with pediatric pulmonologists is essential.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Primary interstitial lung disease specific to childhood due to alveolar structure disorder.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Primary interstitial lung disease specific to childhood due to alveolar structure disorder at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Primary interstitial lung disease specific to childhood due to alveolar structure disorder.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Primary interstitial lung disease specific to childhood due to alveolar structure disorder.
Community
No community posts yet. Be the first to share your experience with Primary interstitial lung disease specific to childhood due to alveolar structure disorder.
Start the conversation →Latest news about Primary interstitial lung disease specific to childhood due to alveolar structure disorder
No recent news articles for Primary interstitial lung disease specific to childhood due to alveolar structure disorder.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Primary interstitial lung disease specific to childhood due to alveolar structure disorder
What is Primary interstitial lung disease specific to childhood due to alveolar structure disorder?
Primary interstitial lung disease specific to childhood due to alveolar structure disorder (also referred to as childhood ILD related to alveolar structure disorder or chILD due to alveolar structure disorder) is a group of rare lung diseases that affect infants and young children. These conditions are characterized by abnormal development or disruption of the alveolar structures — the tiny air sacs in the lungs where gas exchange occurs. The alveoli may be simplified, enlarged, or structurally disorganized, leading to impaired oxygen exchange and respiratory insufficiency. This category encom
At what age does Primary interstitial lung disease specific to childhood due to alveolar structure disorder typically begin?
Typical onset of Primary interstitial lung disease specific to childhood due to alveolar structure disorder is neonatal. Age of onset can vary across affected individuals.